Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
234.8 CHF
3.21%
Market Closed
Updated:
May 16, 2024
Roche Holding AG
Total Liabilities & Equity
|
Roche Holding AG
Total Liabilities & Equity Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Total Liabilities & Equity
CHf90.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
|
Novartis AG
SIX:NOVN
|
Total Liabilities & Equity
$94.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Total Liabilities & Equity
$9.3m
|
CAGR 3-Years
137%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Total Liabilities & Equity
$17.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Total Liabilities & Equity?
Total Liabilities & Equity
90.5B
CHF
90.5B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Total Liabilities & Equity amounts to 90.5B CHF.
What is Roche Holding AG's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
4%
4%
Over the last year, the Total Liabilities & Equity growth was 3%. The average annual Total Liabilities & Equity growth rates for Roche Holding AG have been 2% over the past three years , 3% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
